Clinical trial
Clopidogrel Versus Aspirin Monotherapy After Percutaneous Coronary Intervention and Standard Dual Antiplatelet Therapy in Patients At High Risk for Recurrent Ischemic Events
NCT04418479 is registered in ClinicalTrials.gov with Joo-Yong Hahn as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clopidogrel Versus Aspirin Monotherapy After Percutaneous Coronary Intervention and Standard Dual Antiplatelet Therapy in Patients At High Risk for Recurrent Ischemic Events
- Lead sponsor
- Joo-Yong Hahn
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 10, 2020
- Completion date
- November 12, 2024
- Enrollment
- 5,506 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.